ExodusPoint Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,560
| Closed | -$76K | – | 1329 |
|
|
2023
Q4 | $76K | Sell |
21,560
-39,089
| -64% | -$138K | ﹤0.01% | 1298 |
|
|
2023
Q3 | $405K | Buy |
+60,649
| New | +$405K | ﹤0.01% | 1267 |
|
|
2023
Q2 | – | Sell |
-13,800
| Closed | -$137K | – | 1727 |
|
|
2023
Q1 | $137K | Buy |
+13,800
| New | +$137K | ﹤0.01% | 1513 |
|
|
2022
Q4 | – | Sell |
-33,685
| Closed | -$180K | – | 1548 |
|
|
2022
Q3 | $180K | Buy |
33,685
+11,190
| +50% | +$59.8K | ﹤0.01% | 1633 |
|
|
2022
Q2 | $90K | Buy |
22,495
+2,364
| +12% | +$9.46K | ﹤0.01% | 1701 |
|
|
2022
Q1 | $89K | Sell |
20,131
-4,900
| -20% | -$21.7K | ﹤0.01% | 1951 |
|
|
2021
Q4 | $100K | Sell |
25,031
-5,463
| -18% | -$21.8K | ﹤0.01% | 1907 |
|
|
2021
Q3 | $268K | Buy |
+30,494
| New | +$268K | ﹤0.01% | 1612 |
|
|
2021
Q2 | – | Sell |
-156,414
| Closed | -$1.86M | – | 2209 |
|
|
2021
Q1 | $1.86M | Buy |
156,414
+16,894
| +12% | +$201K | 0.03% | 561 |
|
|
2020
Q4 | $957K | Buy |
139,520
+128,098
| +1,122% | +$879K | 0.01% | 824 |
|
|
2020
Q3 | $85K | Sell |
11,422
-1,663
| -13% | -$12.4K | ﹤0.01% | 1547 |
|
|
2020
Q2 | $55K | Buy |
+13,085
| New | +$55K | ﹤0.01% | 1655 |
|